Kat - OmicsDI

Show results for

Unknown (387)
Genomics (133)
Transcriptomics (125)
Proteomics (39)
Other (5)
Metabolomics (4)
Methylation profiling (1)

Organisms

Homo sapiens (67)
Mus musculus (42)
Andropogon gerardi (24)
Bacteria (24)
Bartonella quintana JK 31 (24)
Canis lupus familiaris (24)
Cnidaria (24)
Saccharomyces cerevisiae (17)
Drosophila melanogaster (12)
Schizosaccharomyces pombe (9)
Arabidopsis thaliana (6)
Toxoplasma gondii (4)
Thermus thermophilus HB8 (3)
Heterocephalus glaber (3)
Bathyergus suillus (2)
Neisseria meningitidis (2)
Danio rerio (2)
Escherichia coli (2)
Mycosarcoma maydis (2)
Aspergillus nidulans (1)
Schizosaccharomyces pombe 972h- (1)
Bacillus subtilis (1)
Saccharomyces cerevisiae S288C (1)
Aedes aegypti (1)
Cryptococcus neoformans (1)
Escherichia coli str. K-12 substr. MG1655 (1)
Shewanella algae (1)
Caenorhabditis elegans (1)
Rattus norvegicus (1)
Mycolicibacterium smegmatis MC2 51 (1)

Organisms

Homo sapiens (38)
Mus musculus (18)
Solanum tuberosum (5)
Citrus reticulata (3)
Toxoplasma gondii (3)
Mycosarcoma maydis (2)
Suncus murinus (1)
Shewanella algae (1)
Caenorhabditis elegans (1)
Arabidopsis thaliana (1)
Rattus norvegicus (1)

Repository

biostudies-arrayexpress (119)
ENA (85)
geo (59)
pride (24)
MassIVE (9)
jPOST (5)
MetaboLights (4)
EGA (1)
iProX (1)

Tissue

Cell culture (7)
Blood (2)
Blood cell (2)
Endothelial cell (2)
Epithelial cell (2)
Fibroblast (2)
B cell (1)
Bone marrow (1)
Cervical epithelial cell (1)
Embryonic stem cell (1)
Lymph node (1)
Permanent cell line cell (1)
Plant cell (1)
Root (1)
Seedling (1)

Disease

Disease free (2)
Glioblastoma multiforme (1)
Cell type cancer (1)
Cervix carcinoma (1)
Colon cancer (1)
Lymphoma (1)

Technology Type

Mass Spectrometry (24)
Shotgun proteomics (8)
Chemical cross-linking coupled with mass spectrometry proteomics (4)
Data-independent acquisition (4)
Affinity purification coupled with mass spectrometry proteomics (3)
Bottom-up proteomics (3)
Mass spectrometry assay (2)
Mass spectrometry (2)
Gel-based experiment (2)
SRM/MRM (2)
DiaPASEF (1)

Instrument Platform

Illumina NovaSeq 6000 (3)
LTQ (3)
PromethION (2)
PacBio RS II (2)
Axon GenePix 4000B scanning hardware (2)
Illumina HiSeq 2500 (2)
NextSeq 500 (2)
Orbitrap Eclipse (2)
Orbitrap Fusion Lumos (2)
Axon GenePix 4000A scanning hardware (1)
Other (1)
DNA Microarray Scanner BA [Agilent Technologies] (1)
Illumina Genome Analyzer II (1)
Vortex (1)
LTQ Orbitrap (1)
LTQ Orbitrap XL (1)
Orbitrap Exploris 480 (1)
Orbitrap Fusion (1)
Flow injection analysis MS - negative (1)
Flow injection analysis MS - positive (1)
Liquid Chromatography MS - alternating (1)
MaXis (Bruker) (1)
Liquid Chromatography MS - alternating - hilic (1)
Liquid Chromatography MS - alternating - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)
Liquid Chromatography MS - negative - reverse phase (1)

Publication Date

2026 (23)
2010 (19)
2013 (18)
2025 (18)
2024 (16)
2021 (14)
2014 (13)
2015 (12)
2011 (12)
2023 (9)
2016 (9)
2012 (9)
2009 (8)
2018 (7)
2022 (6)
2020 (6)
2008 (5)
2007 (5)
2019 (5)
2017 (3)
2006 (2)
2005 (1)
2004 (1)

CHEBI ID

CHEBI:27911 (2)
CHEBI:16543 (2)
CHEBI:16264 (2)
CHEBI:17822 (2)
CHEBI:16680 (2)
CHEBI:26271 (2)
CHEBI:17858 (2)
CHEBI:16856 (2)
CHEBI:18237 (2)
CHEBI:22660 (2)
CHEBI:22653 (2)
CHEBI:27570 (2)
CHEBI:18186 (2)
CHEBI:16811 (2)
CHEBI:16695 (2)
CHEBI:17533 (2)
CHEBI:16576 (2)
CHEBI:17515 (2)
CHEBI:17361 (2)
CHEBI:25017 (2)
CHEBI:5457 (2)
CHEBI:15428 (2)
CHEBI:17148 (2)
CHEBI:17154 (2)
CHEBI:16865 (2)
CHEBI:17310 (2)
CHEBI:17957 (2)
CHEBI:17509 (2)
CHEBI:17012 (2)
CHEBI:17764 (2)

Metabolite Name

440.0420@4.43min (1)
Sinapoylglucose (1)
471.083@4.43 (1)
Hydroxycamalexin hexoside2 (1)
Hydroxycamalexin hexoside1 (1)
363.069@5.95 (1)
205.08@5.21 (1)
191.143@8.09 (1)
161.096@8.03 (1)
D-carnitinyl-CoA (1)
Crotonobetainyl-CoA (1)
Adenosine thiamine triphosphate (1)
6-hydroxymethyl-dihydropterin pyrophosphate (1)
Hexadecanoyl-phosphate (n-C16:0) (1)
Psicoselysine (1)
Ferric 2,3-dihydroxybenzoylserine (1)
Dihydromonapterin (1)
Tetradecenoate (n-C14:1) (1)
L-alanine-L-glutamate (1)
L-alanine-D-glutamate (1)
Cis-3-(3-carboxyethyl)-3,5-cyclohexadiene-1,2-diol (1)
(2R,4S)-2-methyl-2,3,3,4-tetrahydroxytetrahydrofuran (1)
5'-deoxyribose (1)
Octanoate (protein bound) (1)
3-Aminoacrylate (1)
Cyclic pyranopterin monophosphate (1)
L-ascorbate-6-phosphate (1)
Dehydroglycine (1)
Gamma-glutamyl-gamma aminobutyric acid (1)
3-keto-L-gulonate-6-phosphate (1)

First Public Date

2026 (19)
2025 (19)
2024 (14)
2021 (13)
2014 (6)
2018 (3)
2023 (2)
2022 (2)
2019 (2)
2017 (2)
2016 (1)
2015 (1)
2011 (1)

Classification

protozoa (3)

Study type

Transcription profiling by array (60)
ChIP-seq (22)
RNA-seq of coding RNA (9)
RNA-seq of non coding RNA (7)
ChIP-chip by tiling array (6)
DNA-seq (4)
ChIP-chip by array (3)
Unknown experiment type (2)
Transcription profiling by SAGE (1)
MNase-seq (1)
Comparative genomic hybridization by array (1)
Other (1)
Methylation profiling by array (1)
Methylation profiling by high throughput sequencing (1)

Release Date

2023 (47)
2025 (45)
2021 (43)
2024 (37)
2022 (37)
2016 (27)
2015 (27)
2010 (27)
2018 (25)
2017 (25)
2013 (24)
2020 (22)
2019 (22)
2014 (21)
2012 (15)
2011 (14)
2009 (13)
2026 (12)
2008 (8)
2007 (5)
2002 (3)
2006 (2)
2004 (2)
2005 (1)
2003 (1)
2000 (1)

Lab affiliation

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA (3)
1. Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada; 2. University of Victoria Genome BC Proteomics Centre, University of Victoria, Victoria, British Columbia, Canada; 3. Gerald Bronfman Department of Oncology, Jewish General Hospital, Montreal, Quebec, Canada; 4. Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, Quebec, Canada (2)
1. Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada; 2. University of Victoria Genome BC Proteomics Centre, University of Victoria, Victoria, British Columbia, Canada; 3. Gerald Bronfman Department of Oncology, Jewish General Hospital, Montreal, Quebec, Canada; 4. Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, Quebec, Canada (1)
1. University of Victoria Genome BC Proteomics Centre, University of Victoria, Victoria, British Columbia, Canada 2. Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, Quebec, Canada 3. Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada 4. Gerald Bronfman Department of Oncology, Jewish General Hospital, Montreal, Quebec, Canada (1)
Chair of Proteomics and Bioanalytics, Technical University of Munich (1)
Chemical Biology Laboratory, National Cancer Institute (1)
Chinese Academy of Sciences Shanghai Institute of Materia Medica (1)
Department of Biochemistry and Biophysics, School of Basic Medical Sciences, Peking University Health Science Center, #38 Xueyuan Road, Beijing 100191, China (1)
Department of Biomedicine, University of Bergen (1)
Department of Hematology, Erasmus MC, Rotterdam, the Netherlands (1)
Department of Immunology, Microbiology and Parsitology Faculty of Science and Technology University of the Basque Country (UPV/EHU) (1)
Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands (1)
Department of Neurology, Erasmus MC, Rotterdam, The Netherlands (1)
Dept. Plasma Proteins, Sanquin Research, Amsterdam, The Netherlands. Dept. Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands. (1)
European Institute of Oncology (1)
Institute of Science and Technology, Austria, Klosterneuburg. (1)
Ludwig-Maximilians-Universität, Biomedizinisches Centrum (BMC) (1)
Max Planck Institute of Immunobiology and Epigenetics, Stübeweg 51, 79108 Freiburg im Breisgau (1)
Professor of Chemical and Systems Biology at Stanford, USA (1)
Proteomics Unit Max Planck Institute of Immunobiology and Epigenetics (1)
Transcription and Disease Laboratory, Molecular Biology and Genetics Unit, Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore, Karnataka, India (1)

Previous page
1 / 70
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 70
Next page

Sort by:

Relevance

Page size

Gene expression profiling of human anaplastic thyroid carcinoma cells by microarray

In this study, we profiled the change of gene expression by p53 knock-down on anaplastic thyroid carcinoma (ATC) cell line, KAT-18 cells using Applied Biosystem's Microarrays. When compared with the untreated control KAT-18 cells, 2,926 genes were found to have altered expression levels of 2-fold or...

ORGANISM(S): Homo sapiens

2010-06-25 | E-GEOD-12912 | biostudies-arrayexpress

KAT–independent gene regulation by Tip60 promotes ESC self-renewal but not pluripotency

Although histone-modifying enzymes are assumed to function in a manner dependent on their enzymatic activities, this assumption remains untested for many factors. Here we show the Tip60 (Kat5) lysine acetyltransferase (KAT), which is essential for embryonic stem cell (ESC) self-renewal and pre-impla...

ORGANISM(S): Mus musculus

2017-04-06 | GSE85505 | GEO

ASEB: a web server for KAT-specific acetylation site prediction.

Not available

S-EPMC3394258 | biostudies-literature

KAT-Independent Gene Regulation by Tip60 Promotes ESC Self-Renewal but Not Pluripotency.

Not available

S-EPMC5484067 | biostudies-literature

Expression data from MCF-7 cells treated with p300 KAT inhibitor A-485

PRJNA722294 | ENA

p300 KAT Regulates SOX10 Stability and Function in Human Melanoma.

Not available